(Q34075463)

English

A randomized, double-blind, placebo-controlled trial of spironolactone on carotid intima-media thickness in nondiabetic hemodialysis patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

A randomized, double-blind, placebo-controlled trial of spironolactone on carotid intima-media thickness in nondiabetic hemodialysis patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

0 references

placebo-controlled trial

1 reference

based on heuristic

inferred from title

hemodialysis patient

1 reference

based on heuristic

inferred from title

author name string

Antonio Vukusich

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sonia Kunstmann

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Cristian Varela

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Daniela Gainza

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sebastian Bravo

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Daniela Sepulveda

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Gabriel Cavada

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Luis Michea

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Elisa T Marusic

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

3 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Clinical Journal of the American Society of Nephrology

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1380-1387

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

5 July 2018

Atheroma progression in chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

5 July 2018

Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

5 July 2018

Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

5 July 2018

CARMELA: assessment of cardiovascular risk in seven Latin American cities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

5 July 2018

Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

5 July 2018

Aldosterone antagonism in chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

5 July 2018

Chronic kidney disease: effects on the cardiovascular system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

5 July 2018

Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

5 July 2018

Aldosterone blockade: an emerging strategy for abrogating progressive renal disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

5 July 2018

Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

5 July 2018

Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

5 July 2018

Cardiovascular risk in end-stage renal disease: vascular aspects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

5 July 2018

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

5 July 2018

Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

5 July 2018

Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

5 July 2018

"Escape" of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

5 July 2018

Cardiovascular risk factors in chronic renal failure and hemodialysis populations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

5 July 2018

Aldosterone blockade by Spironolactone improves the hypertensive vascular hypertrophy and remodeling in angiotensin II overproducing transgenic mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

28 October 2018

Mechanisms of impaired potassium handling with dual renin-angiotensin-aldosterone blockade in chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

28 October 2018

Intima-media thickness is a useful marker of the extent of coronary artery disease in patients with impaired renal function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

28 October 2018

Kidney function and progression of carotid intima-media thickness in a community study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

28 October 2018

Carotid artery intima-media thickness correlates with oxidative stress in chronic haemodialysis patients with accelerated atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

28 October 2018

Is it time for spironolactone therapy in dialysis patients?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

28 October 2018

Association between carotid artery intima-media thickness and cardiovascular risk factors in CKD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

28 October 2018

Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

28 October 2018

Effect of spironolactone on K(+) homeostasis and ENaC expression in lymphocytes from chronic hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

28 October 2018

Regression of carotid and femoral artery intima-media thickness in familial hypercholesterolemia: treatment with simvastatin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924413

28 October 2018

Hyperkalemia resulting from captopril administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/20522535

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20522535

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gender differences in carotid intima-media thickness in patients with suspected coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20522535

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aldosterone: a mediator of myocardial necrosis and renal arteriopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20522535

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Common carotid artery intima-media thickness and the risk of stroke recurrence

1 reference

https://pubmed.ncbi.nlm.nih.gov/20522535

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotens

1 reference

https://pubmed.ncbi.nlm.nih.gov/20522535

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2215/CJN.09421209

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34075463&oldid=2165141210"